News & Updates

A higher placental weight (PW) often results in higher offspring BMI, but its effect lessens by the age of 9 years, reveals a study.

Among women with a history of pregnancy loss, prior exposure to Chlamydia trachomatis poses an increased risk of miscarriage, as reported in a study.

A single injection of cross-linked hyaluronic acid appears to help reduce vulvovaginal symptoms (VVA) and improve sexual dysfunction in postmenopausal women, as shown in a study.

Maternal use of the migraine drug triptans before or during pregnancy does not appear to put infants at risk of developing neurodevelopmental disorders, according to a study.

Noninvasive approaches such as mindfulness training and transcranial direct current stimulation (tDCS) hold therapeutic potential in women with situational urgency urinary incontinence (UUI), as shown in a study.

COVID-19 vaccination during pregnancy poses no increased risk of miscarriage, as shown in a case–control study.

Women with opioid use disorder (OUD) treated with buprenorphine during pregnancy had significantly lower rates of adverse maternal and infant outcomes than those who did not receive treatment, according to a study presented at PAS 2025.

In Singaporean women, improved physical performance appears to reduce the risk of depression during midlife, whereas worsening menopausal symptoms and pelvic floor dysfunction contribute to a risk increase, according to a local study.

During early pregnancy, high levels of maternal estradiol (E2) appear to contribute to altered glucose metabolism and greater metabolic risks in children conceived via in vitro fertilization (IVF), reports a recent study.